Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Efficacy and safety of intravenous ulinastatin versus placebo along with standard supportive care in subjects with mild or severe acute pancreatitis.

Abraham P, Rodriques J, Moulick N, Dharap S, Chafekar N, Verma PK, Agrawal A, Prabhakar B, Basavaraj A, Shah A, Chaphekar AP, Biswal UC, Malhan ST, Bakshi G.

J Assoc Physicians India. 2013 Aug;61(8):535-8.

PMID:
24818336
2.

Randomized clinical trial to assess the efficacy of ulinastatin for postoperative pancreatitis following pancreaticoduodenectomy.

Uemura K, Murakami Y, Hayashidani Y, Sudo T, Hashimoto Y, Ohge H, Sueda T.

J Surg Oncol. 2008 Oct 1;98(5):309-13. doi: 10.1002/jso.21098.

PMID:
18548482
3.

Prospective, randomized, double-blind, placebo-controlled trial of ulinastatin for prevention of hyperenzymemia after double balloon endoscopy via the antegrade approach.

Itaba S, Nakamura K, Aso A, Tokunaga S, Akiho H, Ihara E, Iboshi Y, Iwasa T, Akahoshi K, Ito T, Takayanagi R.

Dig Endosc. 2013 Jul;25(4):421-7. doi: 10.1111/den.12014. Epub 2012 Dec 20.

PMID:
23368820
4.

Effect of Somatostatin, Ulinastatin and Gabexate on the Treatment of Severe Acute Pancreatitis.

Wang G, Liu Y, Zhou SF, Qiu P, Xu L, Wen P, Wen J, Xiao X.

Am J Med Sci. 2016 May;351(5):506-12. doi: 10.1016/j.amjms.2016.03.013. Epub 2016 Mar 31.

PMID:
27140710
5.

Intravenous administration of ulinastatin (human urinary trypsin inhibitor) in severe sepsis: a multicenter randomized controlled study.

Karnad DR, Bhadade R, Verma PK, Moulick ND, Daga MK, Chafekar ND, Iyer S.

Intensive Care Med. 2014 Jun;40(6):830-8. doi: 10.1007/s00134-014-3278-8. Epub 2014 Apr 16.

6.

Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography: a randomized, controlled trial.

Tsujino T, Komatsu Y, Isayama H, Hirano K, Sasahira N, Yamamoto N, Toda N, Ito Y, Nakai Y, Tada M, Matsumura M, Yoshida H, Kawabe T, Shiratori Y, Omata M.

Clin Gastroenterol Hepatol. 2005 Apr;3(4):376-83.

PMID:
15822043
7.

The results of the Tokyo trial of prevention of post-ERCP pancreatitis with risperidone (Tokyo P3R): a multicenter, randomized, phase II, non-placebo-controlled trial.

Tsujino T, Isayama H, Nakai Y, Ito Y, Togawa O, Toda N, Arizumi T, Kogure H, Yamamoto K, Mizuno S, Yashima Y, Yagioka H, Sasaki T, Matsubara S, Yamamoto N, Hirano K, Sasahira N, Tada M, Koike K.

J Gastroenterol. 2013 Aug;48(8):982-8. doi: 10.1007/s00535-012-0698-5. Epub 2012 Oct 24.

PMID:
23090004
8.

The effect of somatostatin, ulinastatin and Salvia miltiorrhiza on severe acute pancreatitis treatment.

Wang G, Wen J, Wilbur RR, Wen P, Zhou SF, Xiao X.

Am J Med Sci. 2013 Nov;346(5):371-6. doi: 10.1097/MAJ.0b013e31827aa2bc.

PMID:
23514667
9.

A randomized, double-blind, placebo-controlled, multicenter, repeat-dose study of two intravenous acetaminophen dosing regimens for the treatment of pain after abdominal laparoscopic surgery.

Wininger SJ, Miller H, Minkowitz HS, Royal MA, Ang RY, Breitmeyer JB, Singla NK.

Clin Ther. 2010 Dec;32(14):2348-69. doi: 10.1016/j.clinthera.2010.12.011.

PMID:
21353105
10.

[Clinical study on effects of ulinastatin on patients with systemic inflammatory response syndrome].

Shao YM, Zhang LQ, Deng LH, Yao HG.

Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2005 Apr;17(4):228-30. Chinese.

11.

[Procaine infusion for pain treatment of acute pancreatitis: a randomized, placebo-controlled double-blind trial].

Wilms B, Meffert KS, Schultes B.

Dtsch Med Wochenschr. 2010 Nov;135(46):2290-5. doi: 10.1055/s-0030-1267512. Epub 2010 Nov 9. German.

PMID:
21064010
12.

Preventive effects of ulinastatin on complications related to pancreaticoduodenectomy: A Consort-prospective, randomized, double-blind, placebo-controlled trial.

Zhang H, Tan C, Wang X, Kang D, Chen Y, Xiong J, Tian B, Li K, Hu W, Chen X, Ke N, Li A, Liu X.

Medicine (Baltimore). 2016 Jun;95(24):e3731. doi: 10.1097/MD.0000000000003731.

13.
14.

Safety and tolerability of high-dose ulinastatin after 2-hour intravenous infusion in adult healthy Chinese volunteers: A randomized, double-blind, placebo-controlled, ascending-dose study.

Chen Q, Hu C, Liu Y, Liu Y, Wang W, Zheng H, Rong L, Jia J, Sun S, Yu C, Liu YM.

PLoS One. 2017 May 11;12(5):e0177425. doi: 10.1371/journal.pone.0177425. eCollection 2017.

15.

Randomised, double blind, placebo controlled trial of intravenous antioxidant (n-acetylcysteine, selenium, vitamin C) therapy in severe acute pancreatitis.

Siriwardena AK, Mason JM, Balachandra S, Bagul A, Galloway S, Formela L, Hardman JG, Jamdar S.

Gut. 2007 Oct;56(10):1439-44. Epub 2007 Mar 13.

16.

Protective effect of ulinastatin in patients with non-small cell lung cancer after radiation therapy: a randomized, placebo-controlled study.

Bao P, Zhao W, Li Y, Liu Y, Zhou Y, Liu C.

Med Oncol. 2015 Jan;32(1):405. doi: 10.1007/s12032-014-0405-x. Epub 2014 Dec 12.

PMID:
25502081
17.

Ulinastatin shows preventive effect on post-endoscopic retrograde cholangiopancreatography pancreatitis in a multicenter prospective randomized study.

Fujishiro H, Adachi K, Imaoka T, Hashimoto T, Kohge N, Moriyama N, Suetsugu H, Kawashima K, Komazawa Y, Ishimura N, Ishihara S, Amano Y, Kinoshita Y.

J Gastroenterol Hepatol. 2006 Jun;21(6):1065-9.

PMID:
16724996
18.

Preventive effects of ulinastatin on post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: a prospective, randomized, placebo-controlled trial.

Yoo JW, Ryu JK, Lee SH, Woo SM, Park JK, Yoon WJ, Lee JK, Lee KH, Hwang JH, Kim YT, Yoon YB.

Pancreas. 2008 Nov;37(4):366-70. doi: 10.1097/MPA.0b013e31817f528f.

PMID:
18953247
19.
20.

Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitis.

Johnson CD, Kingsnorth AN, Imrie CW, McMahon MJ, Neoptolemos JP, McKay C, Toh SK, Skaife P, Leeder PC, Wilson P, Larvin M, Curtis LD.

Gut. 2001 Jan;48(1):62-9.

Supplemental Content

Support Center